F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs
The agency announced moves to cut regulatory obstacles for the [...]
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices
In a first, Colorado will cap the price of Enbrel, [...]
FDA OKs New Keytruda Shot for Cancer
The F.D.A. approved Merck’s injected version of its blockbuster infusion [...]
The Pharmaceutical Industry Heads Into Elon Musk’s Wood Chipper
Who needs N.I.H. grants? A lot of red-state universities, for [...]
Drug Company to Share Revenues With Indigenous People Who Donated Their Genes
Variant Bio, a small biotech company based in Seattle, is [...]
Pfizer Stopped Us From Getting Ozempic Decades Ago
Researchers identified one key breakthrough for GLP-1 drugs in the [...]
Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?
A study of Gila monster venom helped start the revolution [...]
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Many middle-income countries are left out of the deal, widening [...]
Six Reasons Drug Prices Are So High in the U.S.
Research shows prices in the United States are nearly double [...]
Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Research
In a wide-ranging interview, Dr. Monica M. Bertagnolli, the director [...]